(Journal Article): The Role of HLA Class I Gene Variation in Autoimmune Diabetes
 
Sia C, Weinem M (Department of Immunology, United Biomedical Inc., 25 Davids Drive, Hauppage, New York 11788, USA., csia@unitedbiomedical.com )
 
IN: Rev Diabetic Stud 2005; 2(2):97-109
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

Fulltext:    HTML  PDF

ABSTRACT: The use of DNA-based genetic typing has enabled the identification of type 1 diabetes mellitus (T1DM) susceptible and protective major histocompatibility complex (MHC) class II alleles and haplotypes. The application of this approach has also progressed to locate MHC class I alleles that contribute to the clinicopathology of T1DM. Recent studies have shown that a widespread involvement of genes from the MHC class I gene region in the clinicopathology of T1DM. These genes are shown to be involved in contributing to progression from the preclinical stage of the disease, which is characterized by the occurrence of islet-specific antibodies, to clinical disease and also to the occurrence of autoimmunity. They can either contribute directly to disease development or indirectly in concert with other susceptible MHC class II alleles or haplotypes via linkage disequilibrium. Class I alleles may also be negatively associated with T1DM. These findings are useful for the development of future strategies in designing tolerogenic approaches for the prevention or even reversal of T1DM. In this article, the latest evidence for the different kinds of participation of HLA class I genes in the etiology of T1DM is reviewed. A meta-analysis which included existing association studies was also carried out in order to re-assess the relevance of class I genes in diabetes development. The analysis of an enlarged heterogeneous sample confirmed the involvement of previously detected serotypes in the etiology of T1DM, such as A24, B8 and B18, and revealed hitherto unknown associations with B60 and B62. The analysis points out that much of the conflicting results of previous association studies originates from inadequate sample sizes and accentuates the value of future investigations of larger samples for identifying linkage in multigenic diseases.

TYPE OF PUBLICATION: Original article

REFERENCES:

1. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A 1995. 92(19):8560-8565.
2. Aitman TJ, Todd JA. Molecular genetics of diabetes mellitus. Baillieres Clin Endocrinol Metab. 1995. 9(3):631-656.
3. Deng GY, Muir A, Maclaren NK, She JX. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet 1995. 56(2):528-534.
4. Sia C, Weinem M. Genetic susceptibility to type 1 diabetes in the intracellular pathway of antigen processing - a subject review and cross-study comparison. Rev Diabetic Stud 2005. 2:40-52.
5. Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Falorni A, Sanjeevi CB. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type 1 diabetes. Diabetologia 2000. 43(4):507-514.
6. Green A, Svejgaard A, Platz P, Ryder LP, Jakobsen BK, Morton NE, MacLean CJ. The genetic susceptibility to insulin-dependent diabetes mellitus: combined segregation and linkage analysis. Genet Epidemiol 1985. 2(1):1-15.
7. Chang YW, Lam KS, Hawkins BR. Strong association between DQA1/DQB1 genotype and early-onset IDDM in Chinese: the association is with alleles rather than specific residues. Eur J Immunogenet 1998. 25(4):273-280.
8. Chen BH, Chiang CH, Lin SR, Chao MG, Tsai ST. The influence of age at onset and gender on the HLA-DQA1, DQB1 association in Chinese children with insulin dependent diabetes mellitus. Hum Immunol 1999. 60(11):1131-1137.
9. Komulainen J, Kulmala P, Savola K, Lounamaa R, Ilonen J, Reijonen H, Knip M, Akerblom HK. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1999. 22(12):1950-1955.
10. Tait BD, Harrison LC, Drummond BP, Stewart V, Varney MD, Honeyman MC. HLA antigens and age at diagnosis of insulin-dependent Diabetes Mellitus. Hum Immunol 1995. 42:116-122.
11. Valdes AM, Thomson G, Erlich HA, Noble JA. Association between type 1 diabetes age of onset and HLA among sibling pairs. Diabetes 1999. 48(8):1658-1661.
12. Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol 2005. 66(3):301-313.
13. Iafusco D, Prisco F, Stoppoloni O, Accolla RS, Tosi G. HLA-DQ genotype in early onset insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 1999. 12(6):887-890.
14. Svejgaard A, Jakobsen BK, Platz P, Ryder LP, Nerup J, Christy M, Borch-Johnsen K, Parving HH, Deckert T, Molsted-Pedersen L, et al. HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 1986. 28(4):237-244.
15. Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. J Autoimmun 1998. 11(6):643-650.
16. Shield JP, Wadsworth EJ, Baum JD. The genetic contribution to disease pathogenesis in childhood diabetes is greatest in the very young. Diabet Med 1995. 12(5):377-379.
17. Savola K, Bonifacio E, Sabbah E, Kulmala P, Vahasalo P, Karjalainen J, Tuomilehto-Wolf E, Merilainen J, Akerblom HK, Knip M. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. Diabetologia 1998. 41(4):424-429.
18. Tait BD, Colman PG, Morahan G, Marchinovska L, Dore E, Gellert S, Honeyman Mc, Stephen K, Loth A. HLA genes associated with autoimmunity and progression to disease in Type 1 Diabetes. Tissue Antigens 2003. 61(2):146-153.
19. Fennessy M, Metcalfe K, Hitman GA, Niven M, Biro PA, Tuomilehto J, Tuomilehto-Wolf E. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 1994. 37(9):937-944.
20. Yamanouchi J, Verdaguer J, Han B, Amrani A, Serra P, Santamaria P. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. J Immunol 2003. 171(12):6900-6909.
21. Yoon JW, Jun HS, Santamaria P. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 1998. 27(2):109-122.
22. DiLorenzo TP, Serreze DV. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. Immunol Rev 2005. 204:250-263.
23. Nikolic-Zugic J, Carbone FR. Peptide presentation by class-I major histocompatibility complex molecules. Immunol Res 1991.10:54-65.
24. Nakanishi K, Kobayashi T, Murase T, Nakatsuji T, Inoko H, Tsuji K, Kosaka K. Association of HLA-A24 with complete beta-cell destruction in IDDM. Diabetes 1993. 42:1086-1096.
25. Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD. Analysis Of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol Med 1995. 1:576-582.
26. Ono SJ, Issa-Chergui B, Colle E, Guttmann RD, Seemayer TA, Fuks A. IDDM in BB rats. Enhanced MHC class I heavy-chain gene expression in pancreatic islets. Diabetes 1988. 37(10):1411-1418.
27. Panagiotopoulos C, Qin H, Tan R, Verchere CB. Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes. Diabetes 2003. 52(11):2647-2651.
28. Panina-Bordignon P, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 1995. 181(5):1923-1927.
29. Rolandsson O, Hagg E, Janer M, Rutledge E, Gaur LK, Nilsson M, Hallmans G, Lernmark A. High GAD65 autoantibody levels in nondiabetic adults are associated with HLA but not with CTLA-4 or INS VNTR. J Intern Med 2003. 253(4):447-453.
30. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994. 94(5):2125-2129.
31. Tanigaki N, Fruci D, Chersi A, Falasca G, Tosi R, Butler RH. HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. Hum Immunol 1994. 39(3):155-162.
32. Kuzushima K, Sun R, van Bleek GM, Vegh Z, Nathenson SG. The role of self peptides in the allogeneic cross-reactivity of CTLs. J Immunol 1995. 155(2):594-601.
33. Fruci D, Greco G, Vigneti E, Tanigaki N, Butler RH, Tosi R. The peptide-binding specificity of HLA-B27 subtype (B*2705) analyzed by the use of polyalanine model peptides. Hum Immunol 1994. 41(1):34-38.
34. Hiemstra HS, Schloot NC, van Veelen PA, Willemen SJ, Franken KL, van Rood JJ, de Vries RR, Chaudhuri A, Behan PO, Drijfhout JW, Roep BO. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A 2001. 98(7):3988-3991.
35. Atkinson MA. Molecular mimicry and the pathogenesis of insulin-dependent diabetes mellitus: still just an attractive hypothesis. Ann Med 1997. 29(5):393-399.
36. Schloot NC, Willemen SJ, Duinkerken G, Drijfhout JW, de Vries RR, Roep BO. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart. Hum Immunol 2001. 62(4):299-309.
37. Segurado OG, Arnaiz-Villena A, Wank R, Schendel DJ. The multifactorial nature of MHC-linked susceptibility to insulin-dependent diabetes. Autoimmunity 1993.15(1):85-89.
38. Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS, Leslie RD. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 2001. 44(3):354-362.
39. Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, Poulsen JE, Ryder LP, Nielsen LS, Thomsen M, Svejgaard A. HLA antigens and diabetes mellitus. Lancet 1974. 2:864-866.
40. Svejgaard A, Platz P, Ryder LP. Insulin dependent diabetes mellitus. In: Terasaki PI (Editor), Histocompatibility Testing 1980, UCLA Tissue Typing Laboratory, Los Angeles 1981, pp. 638-656.
41. McCombs CC, Michalski JP, deShazo R, Bozelka B, Lane JT. Immune abnormalities associated with HLA-B8: lymphocyte subsets and functional correlates. Clin Immunol Immunopathol 1986. 39(1):112-120.
42. Kobayashi H, Kimura S, Aoki N, Sato K, Celis E, Katagiri M. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells. Immunogenetics 2001. 53(8):626-633.
43. Boyle LH, Goodall JC, Gaston JS. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells. Immunology 2004. 112(1):54-63.
44. Mailliard RB, Egawa S, Cai Q, Kalinska A, Bykovskaya SN, Lotze MT, Kapsenberg ML, Storkus WJ, Kalinski P. Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses. J Exp Med 2002. 195(4):473-483.
45. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986. 324(6093):163-166.
46. Bugawan TL, Apple R, Erlich HA. A method for typing polymorphism at the HLA-A locus using PCR amplification and immobilized oligonucleotide probes. Tissue Antigens 1994. 44(3):137-147.
47. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987. 40:1-14.
48. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995. 11:241-247.
49. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999. 167:257-274.
50. Nejentsev S, Reijonen H, Adojaan B, Kovalchuk L, Schnevs A, Schwartz EI, Akerblom HK, Ilonen J. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 1997. 46(11):1888-1892.
51. Bugawan Tl, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM, Petrone A, Buzzetti R, Pozzilli P, Erlich HA. The association of specific HLA class I and II alleles with type 1 diabetics among Filipinos. Tissue Antigens 2002. 59(6):452-469.
52. Nakanishi K, Kobayashi T, Inoko H, Tsuji K, Murase T, Kosaka K. Residual beta-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy. Diabetes 1995. 44:1334-1339.
53. Fujisawa T, Ikegami H, Kawaguchi Y, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Shima K, Ogihara T. Class I HLA is associated with age-at onset of IDDM, while class II HLA confers susceptibility to IDDM. Diabetologia 1995. 38:1493-1495.
54. Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, Erlich HA. The HLA Class 1 A locus affects susceptibility to Type 1 diabetics. Hum Immunol 2002. 63(8):657-664.
55. Pitkaniemi J, Hakulinen T, Nasanen J, Tuomilehto-Wolf E, Tuomilehto J, DiMe Study Group. Class I and II HLA genes are associated with susceptibility and age at onset in Finnish families with type 1 diabetes. Hum Hered 2004. 57(2):69-79.
56. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993. 52(3):506-516.